Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
66.80
+1.20 (1.83%)
Jul 24, 2026, 5:29 PM CET

STO:IBT.B Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0-00.080.010.09
Revenue Growth
---94.80%541.67%-87.23%-69.87%
Gross Profit
0-00.080.010.09
Operating Income
-75-69-145.34-134.62-65.81-44.58
Net Income
-71.36-65.17-136.91-123.07-65.45-44.99
Earnings Per Share
-5.30-4.84-10.16-9.95-5.83-4.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
131.93144.01223.39329.06335.84386.75
Net Cash Growth
-31.20%-35.53%-32.11%-2.02%-13.16%-8.66%
Cash & Investments
131.93144.01223.39329.06335.84386.75
Net Cash Per Share
9.7910.6918.0726.6129.9234.45

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-56.78-72.34-113.13-101.22-85.8-55.62
Free Cash Flow
-56.78-72.34-113.13-101.22-85.8-55.62
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---3633580.00%-174827.00%-548400.00%-47423.40%
Pretax Margin
---3422625.00%-159828.57%-545425.00%-47862.77%
Profit Margin
---3422630.00%-159829.00%-545425.00%-47862.80%
FCF Margin
---2828330.00%-131453.00%-714958.00%-59173.40%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--180517.0015745.8046775.807977.76